Sponsored sessions will not be made available on demand.
This is a non-promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033
AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations.
Sponsored by:
This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only
Asthma is an inflammatory disease, yet we know that asthma is frequently undertreated and over reliance on SABA is common. This session will look at how the BTS/NICE/SIGN (NG245) can support the care of asthma in primary care and guidance on how to implement with patients.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033.
If you have any questions, comments or queries or would like to request an appointment with an AstraZeneca representative, you can do so here.
AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations.
Sponsored by:
This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only
Prescribing information for Lokelma (sodium zirconium cyclosilicate) is available here
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com or by calling 0800 783 0033
AstraZeneca has provided a sponsorship towards this independent programme. AstraZeneca has had no editorial input into or control over the agenda, content development or choice of speakers, nor opportunity to influence except for the AstraZeneca sponsored symposia presentations.
Sponsored by:
The 20 minute session will cover a little about the following topics in COPD:
This session has been organised and funded by Chiesi Ltd and contains promotional content, PI is available at this meeting.
Sponsored by:
